ArticlePlastic and reconstructive surgery. Global open2025
Disparities in Facial Feminization Surgery Coverage: MassHealth Versus Private Insurance Coverage in Massachusetts.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Facial feminization surgery (FFS) is a component of gender-affirming care for transgender women and includes a variety of surgical procedures with the unified goal of improving patients' quality of life and mitigating mental distress. This study examined insurance coverage, costs, and claim denials for commonly desired FFS procedures in Massachusetts. Methods: Data from the Massachusetts Center for Health Information and Analysis claims database (2016-2021) were analyzed for transgender patients undergoing FFS procedures in Massachusetts. The study focused on comparing costs and denial rates between public and private insurance for frontal bone reduction, eyebrow lift, upper and lower blepharoplasty, canthopexy, rhinoplasty, genioplasty, and tracheal shave. Results: A total of 656 FFS claims were analyzed, with tracheal shave as the most frequently claimed procedure (n = 176), followed by rhinoplasty (n = 165). Private insurance patients incurred 2-4 times higher out-of-pocket costs than public patients, who generally had no copayments. Additionally, private insurance exhibited significantly higher claim denial rates compared with public insurance. Conclusions: Our findings revealed significant differences in insurance coverage, reimbursement, and claim denials for procedures across different insurance types in Massachusetts. These differences arise from varying interpretations of medical necessity, the dual cosmetic and functional nature of certain procedures, and the deeply personal experience of gender dysphoria. Our findings emphasize the need for expanded outcomes research on the efficacy and potential complications of FFS to better inform and enhance the comprehensive care provided to transgender patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.